Skip to main content
European Commission logo
Enterprise Europe Network

A Turkish company is seeking strategic commercialization partners who can aid in the introduction and scaling of our innovative urine analysis technology in new markets

Summary

Profile Type
  • Business request
POD Reference
BRTR20240514011
Term of Validity
14 May 2024 - 14 May 2025
Company's Country
  • Turkey
Type of partnership
  • Commercial agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
Vivo Biotechnology is an innovative SME company based in Istanbul, Türkiye. We specialize in the production and sale of urine test strips and have developed a cutting-edge mobile application that utilizes advanced image-processing algorithms and deep learning for urine analysis through smartphone usage.
Full Description
Vivo Biotechnology is a dynamic small to medium-sized enterprise (SME) located in Istanbul, Turkey, that is at the forefront of medical diagnostic technologies. The company is specialized in the production and commercialization of urine test strips, a key tool in medical diagnostics. Building on its expertise in biotechnology, Vivo Biotechnology has developed an innovative mobile application that leverages advanced image-processing algorithms and deep learning techniques. This application enables users to perform detailed urine analyses using their smartphones, making it a convenient and efficient tool for health monitoring. The integration of these technologies allows for quick, accurate interpretations of urine test strips, potentially transforming how users and healthcare providers manage and monitor health conditions.
Advantages and Innovations
"1. Enhanced Accessibility:
Vivo Biotechnology's mobile application significantly enhances the accessibility of urine testing. By enabling users to conduct tests at their convenience and location of choice, the company removes the logistical barriers associated with traditional laboratory testing. This feature is particularly beneficial for individuals in remote areas or those with mobility constraints.

2. Real-Time Analysis:
The use of advanced image-processing algorithms allows the mobile application to deliver real-time analysis results. This immediate feedback is crucial for the timely management of medical conditions, enabling both patients and healthcare providers to make informed decisions quickly.

3. Cost-Effectiveness:
Vivo Biotechnology's urine test strips and mobile app combination reduce the need for frequent clinic visits for routine tests, thereby saving on travel and consultation costs. This cost-effectiveness makes it an attractive option for both individual users and healthcare systems looking to minimize operational expenses.

4. Accuracy and Precision:
The integration of deep learning technologies ensures that the analysis of urine test strips is both accurate and precise. These technologies improve the app's ability to detect and interpret subtle variations in test strip colors, leading to more reliable diagnoses compared to manual readings.

5. Data Tracking and Management:
The mobile application includes features for tracking and managing historical data, providing users with insightful trends and patterns over time. This data can be instrumental in understanding the progression of a condition and tailoring treatment plans accordingly.

6. Scalability and Innovation:
Vivo Biotechnology is continually refining its technologies. The scalable nature of the mobile app allows for regular updates and integrations of the latest advancements in image processing and machine learning. This commitment to innovation ensures that the application remains
Technical Specification or Expertise Sought
Commercialization Partners: Vivo Biotechnology is seeking strategic commercialization partners who can aid in the introduction and scaling of our innovative urine analysis technology in new markets. Ideal partners should have a robust presence in the healthcare sector and a proven track record of successfully launching medical technologies. They should be well-versed in navigating the regulatory landscapes of their respective regions and capable of executing effective marketing strategies that align with our brand's vision and values. Distributors: We are looking for established distributors with extensive networks within medical and healthcare communities. Distributors should have direct access to potential end-users such as hospitals, clinics, and home care settings. They should be experienced in supply chain management and distribution logistics to ensure that our products are readily available to a broad audience. The role of the distributor will be crucial in managing the sales process, from order fulfillment to after-sales support, ensuring a smooth and efficient customer experience.
Stage of Development
  • Under development
Sustainable Development Goals
  • Goal 3: Good Health and Well-being
IPR status
  • IPR applied but not yet granted

Partner Sought

Expected Role of a Partner
Commercialization Partners: Vivo Biotechnology is seeking strategic commercialization partners who can aid in the introduction and scaling of our innovative urine analysis technology in new markets. Ideal partners should have a robust presence in the healthcare sector and a proven track record of successfully launching medical technologies. They should be well-versed in navigating the regulatory landscapes of their respective regions and capable of executing effective marketing strategies that align with our brand's vision and values. Distributors: We are looking for established distributors with extensive networks within medical and healthcare communities. Distributors should have direct access to potential end-users such as hospitals, clinics, and home care settings. They should be experienced in supply chain management and distribution logistics to ensure that our products are readily available to a broad audience. The role of the distributor will be crucial in managing the sales process, from order fulfillment to after-sales support, ensuring a smooth and efficient customer experience.
Type and Size of Partner
  • SME <=10
  • Big company
  • SME 11-49
  • SME 50 - 249
Type of partnership
  • Commercial agreement

Dissemination

Technology keywords
  • 06005003 - Health information management
Market keywords
  • 05004003 - Laboratory equipment
  • 05004005 - Diagnostic equipment
  • 05004004 - Medical instruments
Targeted countries
  • All countries